Company Valuation: CARE Ratings Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 15,133 19,092 33,416 33,105 43,523 51,811 - -
Change - 26.16% 75.03% -0.93% 31.47% 19.04% - -
Enterprise Value (EV) 15,133 19,092 33,416 33,105 43,523 51,811 51,811 51,811
Change - 26.16% 75.03% -0.93% 31.47% 19.04% 0% 0%
P/E 20.2x 22.8x 33.2x 24.2x 25.5x 25.5x 22x 19.2x
PBR 2.34x 2.67x 4.61x 4.07x 4.68x 4.8x 4.18x 3.64x
PEG - 2x 1.7x 0.7x 1x 1.3x 1.4x 1.3x
Capitalization / Revenue 6.11x 6.68x 10.1x 8.23x 9.2x 9.36x 8.13x 7.12x
EV / Revenue 0x 0x 0x 0x 0x 9.36x 8.13x 7.12x
EV / EBITDA 0x 0x 0x 0x 0x 22.5x 19.2x 16.7x
EV / EBIT 0x 0x 0x 0x 0x 24.2x 20.6x 18x
EV / FCF 0x 0x 0x 0x 0x 23x 20.1x 17.5x
FCF Yield 3.24% 3.71% 2.45% 3.27% 3.2% 4.35% 4.99% 5.71%
Dividend per Share 2 17 17 17 18 14 26.1 28.7 32.7
Rate of return 3.33% 2.64% 1.52% 1.63% 0.97% 1.51% 1.66% 1.9%
EPS 2 25.31 28.17 33.67 45.69 56.83 67.7 78.2 89.8
Distribution rate 67.2% 60.3% 50.5% 39.4% 24.6% 38.6% 36.7% 36.4%
Net sales 1 2,476 2,859 3,317 4,023 4,731 5,535 6,375 7,276
EBITDA 1 798.2 993.4 1,121 1,553 1,974 2,306 2,701 3,102
EBIT 1 721.2 945.2 1,017 1,436 1,830 2,142 2,510 2,877
Net income 1 751.1 835.3 1,005 1,372 1,712 2,032 2,347 2,695
Net Debt - - - - - - - -
Reference price 2 510.45 642.80 1,119.40 1,106.00 1,448.50 1,724.20 1,724.20 1,724.20
Nbr of stocks (in thousands) 29,647 29,701 29,852 29,932 30,047 30,049 - -
Announcement Date 29/05/22 11/05/23 09/05/24 12/05/25 13/05/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
25.31x - - 1.52% 55Cr
28.71x10.19x19.42x0.93% 7.87TCr
31.94x - - 1.88% 320.24Cr
27.43x - - 1.48% 54Cr
Average 28.35x 10.19x 19.42x 1.46% 2.08TCr
Weighted average by Cap. 28.80x 10.19x 19.42x 0.98%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. CARERATING Stock
  4. Valuation CARE Ratings Limited
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!